Patent ID: 7683055

Claim:
A compound having the structure: wherein R 1 is —OH, —NH 2 , —OCH 3 , —OCH 2 CH 2 CH 3 , —OCH(CH 3 ) 2 , —OCH(CH 2 ) 2 , or heteroatom substituted or unsubstituted versions of C 2 -C 10 -alkenyloxy, C 2 -C 10 -alkynyloxy, C 1 -C 10 -aryloxy, C 2 -C 10 -aralkoxy, C 1 -C 10 -acyloxy, C 1 -C 10 -alkylamino, C 2 -C 10 -alkenylamino, C 2 -C 10 -alkynylamino, C 1 -C 10 -arylamino, C 2 -C 10 -aralkylamino, or C 1 -C 10 -amido; wherein R 2 is —OH, —NH 2 , or heteroatom substituted or unsubstituted versions of C 2 -C 10 -alkoxy, C 2 -C 10 -alkenyloxy, C 2 -C 10 -alkynyloxy, C 1 -C 10 -aryloxy, C 2 -C 10 -aralkoxy, C 1 -C 10 -acyloxy, C 1 -C 10 -alkylamino, C 2 -C 10 -alkenylamino, C 2 -C 10 -alkynylamino, C 1 -C 10 -arylamino, C 2 -C 10 -aralkylamino, or C 1 -C 10 -amido; provided that R 1 and R 2 are not both —OH; is —OCH 3 and R 1 is —OH, then the compound is predominantly one enantiomer, and pharmaceutically acceptable salts and optical isomers thereof.